Qms Medical Allied Services Limited · NSE:QMSMEDI
Qms Medical Allied Services — Q1 FY27 Earnings Presentation
31 slides from Qms Medical Allied Services's earnings presentation, Aug 17, 2026
Slide 1: NSE Regulation 30 announcement cover letter
To, National Stock Exchange of India Ltd. Exchange Plaza, C 1, Block G, Bandra - Kurla Complex, Bandra (E), Mumbai – 400 051. Company Symbol: QMSMEDI ISIN: INE0FMW01018 Ref: QMS MEDICAL ALLIED SERVICES LIMITED Sub: Announcement under Regulation 30 of Securities and Exchange Board of India (Listing O
Slide 2: QMS Medical Allied Services Ltd – Investor Presentation Q1FY27
QMS Medical Allied Services Ltd Trusted partner for Medical Services & Patient Journey Programs Investor Presentation – Q1FY27
Slide 3: Disclaimer
Disclaimer This presentation and the accompanying slides (the “Presentation”), has been prepared by QMS Medical Allied Services Ltd (the “Company”), solely for information purposes and do not constitute any offer, recommendation or invitation to purchase or subscribe for any securities, and shall no
Slide 4: Table of Contents
Table of Contents 1 2 3 Q1FY27 Highlights Company Our Overview Offerings 4 5 Opportunity Annual Landscape Financials 3
Slide 5: Q1FY27 Highlights
Q1FY27 Highlights
Slide 6: Management Commentary
Management Commentary Q1FY27 marks a strong start to the year for QMS Medical Allied Services, reflecting the strength of our integrated healthcare business model and the investments made over the past year. We delivered revenue of Rs. 56.9 crore, growing 22% YoY, while EBITDA increased 27% YoY to R
Slide 7: Consolidated Financial Performance – Q1FY27
Consolidated Financial Performance – Q1FY27 Revenue from Operations (Rs Cr) EBITDA (Rs Cr) & EBITDA Margin (%) PAT (Rs Cr) & PAT Margin (%) Segment Revenue Mix (%) Q1FY27 14.1% 14.6% 6.8% 7.0% 22% 27% 25% 41% 59% 56.9 Q1FY26 46.5 8.3 6.5 24% 4.0 3.2 76% Q1FY26 Q1FY27 Q1FY26 Q1FY27 Q1FY26 Q1FY27 Prod
Slide 8: Consolidated Profit & Loss Highlights
Consolidated Profit & Loss Highlights Particulars (Rs Cr) Q1FY27 Q1FY26 Y-o-Y Q4FY26 Q-o-Q Net Revenue from Operations 56.9 46.5 22% 44.4 28% COGS 26.2 25.9 22.3 Employee Expenses 11.2 3.2 5.7 Other Expenses 11.2 10.8 10.5 EBITDA 8.3 6.5 27% 5.9 41% EBITDA Margin (%) 14.6% 14.1% 13.3% Other Income 0
Slide 9: Standalone Profit & Loss Highlights
Standalone Profit & Loss Highlights Particulars (Rs Cr) Q1FY27 Q1FY26 Y-o-Y Q4FY26 Q-o-Q Net Revenue from Operations 52.3 42.3 24% 39.2 34% COGS 25.5 25.4 22.0 Employee Expenses 10.6 2.7 5.2 Other Expenses 9.3 7.9 7.7 EBITDA 7.0 6.3 11% 4.4 60% EBITDA Margin (%) 13.4% 15.0% 11.2% Other Income 0.2 0.
Slide 10: Company Overview
Company Overview
Slide 11: QMS – A Key Player in Integrated Healthcare Ecosystem
QMS – A Key Player in Integrated Healthcare Ecosystem Founded in 1994, QMS has grown from a pharma marketing solutions provider into a trusted healthcare partner. QMS MAS is a leading distributor and marketer of a diverse range of medical products, and has also expanded into high-growth services lik
Slide 12: Unique Value Proposition
Unique Value Proposition 30 years of Industry Experience Promoters & Management Team Holistic Solutions Provider Strong Capabilities / Entry Barrier ✓ Proven expertise in healthcare ✓ Experienced leadership with ✓ Offers integrated smart devices ✓ Pan India network spanning 100+ ecosystem strong pha
Slide 13: Our Remarkable Journey over 30 Years
Our Remarkable Journey over 30 Years 1994 – 2005 2006-2015 2016-2020 2021-2026 • Formation of Queens • Exclusive partnership with Heine • Formation of QMS MAS (Pvt. Ltd) • Launched the Patient Service Marketing Services as a for Diagnostic Equipment in 2008 in 2017 Programs (PSP) services in 2021 so
Slide 14: Distinguished Board of Directors
Distinguished Board of Directors CA Prajwal Poojari Independent Director Mahesh Makhija Dr. D N. Pathak • Chartered Accountant with over 15 years of professional experience. Founder, Chairman and Managing Director Principal Advisor • Currently, serves as an independent director at the company. • Dee
Slide 15: Experienced Management Team
Experienced Management Team Charles James Kaushik Guha Thakurta Abhishek Tiwari Megha Khattar General Manager, B2B Sales & Marketing General Manager, B2B Sales & Marketing General Manager, B2B Sales & Marketing Health Manager • A registered and certified nutritionist, heads • Joined QMS MAS in 1999,
Slide 16: Our Offerings – Products & Services
Our Offerings – Products & Services
Slide 17: Product – Extracting Value in a Competitive Space
1. Product – Extracting Value in a Competitive Space… With a legacy of ~30 years in the industry, we ensure reliable Q-Devices - Launched in 2023, offering a range of Medical/Wellness Devices distribution, foster strong partnerships, and leverage nationwide reach to make healthcare more accessible ✓
Slide 18: Marketed and Distributed through Offline and Online Modes
…Marketed and Distributed through Offline and Online Modes Pharma Cos. and Hospitals Point of Care E-commerce ✓ Collaboration with 50+ (including the Top 10) ✓ Provides strips/consumables during doctor clinic ✓ QMSMEDS: Owned and Developed in-house, for a leading Pharma Companies in India camps, ena
Slide 19: Powering Better Outcomes Through Patient Support Programs & Camps
Powering Better Outcomes Through Patient Support Programs & Camps End-to-End Solutions that Connect Stakeholders. Empower Patients. Deliver Real-World Impact OUR CLIENTS ENGAGE WITH DOCTORS / DOCTORS SHARE PSPs WITH END BENEFICIARIES Pharma | Med Device | HCPs/ Consumers PATIENTS / CONSUMERS PATIENT
Slide 20: B2B Camps – Pharma Driven Health Engagements
2. B2B Camps – Pharma Driven Health Engagements Pharma backed B2B Camps ✓ QMS acts as the backend service provider, enabling pharma companies to conduct structured, short-duration health camps at doctors’ clinics ✓ Pharma companies, through their medical representatives, engage doctors and mobilize
Slide 21: Patient Support Programs – Enhancing Patient Outcomes
3. Patient Support Programs – Enhancing Patient Outcomes… What is Patient Support Programs (PSP)? Scope for QMS PSP provides customized Patient Support and Outreach ✓ QMS manages end-to-end patient management, including reminders, consultations, and Programs designed to improve treatment outcomes fo
Slide 22: Through Our Proprietary Integrated Technology Platform
…through Our Proprietary Integrated Technology Platform Key Advantages QMSMAS Patient Service Ecosystem: Scalable Healthcare Innovation Emphasizes the strengths and value propositions Focus on patient care, scalability (via AWS), and innovative healthcare solutions of the QMSMAS Ecosystem Proprietar
Slide 23: Opportunity Ecosystem
Opportunity Ecosystem
Slide 24: Market Opportunity Landscape
Market Opportunity Landscape The Total Indian Pharma Market is estimated to reach a value of INR 2.4 lakh Cr. in 2024 Key Drivers (source: IQVIA report), of which Retail Sector may account for an estimated Rs. 1.9 lakh Cr • Regulatory Shift: Stricter limits on direct promotions boost PSP growth and
Slide 25: Roadmap to Scalable Growth
Roadmap to Scalable Growth Q-Devices Scale-Up eGrameen Portal Access Driving sustainable growth through Exclusive healthcare vendor – unlocking diagnostics, home-care solutions, and PSP underserved rural and semi-urban integration markets for Q-Devices & partner products Large-Scale Patient Support
Slide 26: Annual Financials
Annual Financials
Slide 27: Key Financial Metrics
Key Financial Metrics Revenue from Operations (Rs Cr) EBITDA (Rs Cr) & EBITDA Margin (%) PAT (Rs Cr) & PAT Margin (%) Earnings Per Share (Rs) 173 156 16.3% 15.0% 15.0% 8.8% 122 7.4% 6.9% 6.7 104 10.9% 6.1% 25.4 25.9 5.0 5.4 13.7 18.3 11.9 3.9 9.0 11.3 6.4 FY23 FY24 FY25 FY26 FY23 FY24 FY25 FY26 FY23
Slide 28: Consolidated Profit & Loss Statement
Consolidated Profit & Loss Statement Particulars (Rs Cr) FY23 FY24 FY25 FY26 CAGR (FY23 to FY26) Net Revenue from Operations 104.0 122.1 156.0 172.9 18% COGS 77.9 79.9 81.6 92.6 Employee Expenses 3.7 5.5 9.6 15.2 Other expenses 11.1 18.4 39.4 39.2 EBITDA 11.3 18.3 25.4 25.9 32% EBITDA Margin (%) 10.
Slide 29: Consolidated Balance Sheet
Consolidated Balance Sheet Equity & Liabilities (Rs Cr) Mar-23 Mar-24 Mar-25 Mar-26 Assets (Rs Cr) Mar-23 Mar-24 Mar-25 Mar-26 Share Capital 17.9 17.9 17.9 19.3 Property, Plant & Equipment and 26.5 25.6 26.8 28.6 Intangible Assets Reserves & Surplus 52.6 60.7 71.9 84.9 Capital Works-in-Progress 0.0
Slide 30: Consolidated Cash Flow Statement
Consolidated Cash Flow Statement Particulars (Rs Cr) FY23 FY24 FY25 FY26 Net Profit Before Tax and Extraordinary items 8.7 12.2 18.7 16.4 Adjustments for: Non-Cash Items / Other Investment or Financial Items 0.7 3.3 3.5 8.8 Operating Profit Before Working Capital Changes 9.4 15.5 22.2 25.2 Changes i
Slide 31: Thank You
Thank You QMS Medical Allied Services Ltd Stellar IR Advisors Ltd Diti Makhija Ankit Jain ditimakhija@qmsmas.com ankit@stellar-ir.com 1A-B/2A-B, Navkala Bharti Building, Road No.3, Santacruz East, Mumbai 400055 +91 22 62398024 www.qmsmas.com A-405, Kanakia Wall Street, Andheri (East), Mumbai 400 093
QMS Medical Allied Services — Q1 FY27 Earnings Presentation on 6ix